Sign in
Taking peopleNo phase

Post-market Clinical Follow-up Study of NEMOST V2

Key facts

Who runs it
EUROS
Where
France5 sites in 1 countryChoose a country to see its sites
Trial code
Status
Recruiting
People taking part
140 people, planned
Started
19 Dec 2025
Expected to end
19 Dec 2033
Type of study
Interventional
Treatments tested
  • NEMOST V2 growing domino
Record updated
11 February 2026

Who can take part

Age
5 years to 17 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 9 criteriaShow less

Who can take part

  • Idiopathic, congenital, neuromuscular, or syndromic scoliosis : Progressive spinal deformity not managed by orthopedic treatment, and requiring primary surgical intervention
  • The patient, as well as their parents or legal guardians, are informed of the participation in the study
  • Patients aged from 5 to 17 yeas old, excepted the one who still have a potential for growth

Who cannot take part

  • acute or chronic, local or systemic infections
  • allergy or intolerance to implanted materials
  • insufficiency or absence of tissue coverage. The NEMOST implant should not be used in a spine that has already been instrumented or fused
  • signs of local inflammation
  • non-reducible scoliosis
  • pathological obesity

The main criteria, as questions

These questions come from the eligibility criteria published for this trial. They help you read the criteria and prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.

  • Are you between 5 and 17 years old?

This trial is currently available in France.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

The NEMOST spinal implant is a growth domino intended for the surgical treatment of progressive scoliosis in children.

Read full original descriptionShow less

As part of post-market surveillance, EUROS is conducting a retrospective and prospective study to collect clinical and radiological data on the NEMOST growth domino.

Retrospective and prospective multicenter post-market surveillance clinical study.

This study is interventional, non-randomized, and uncontrolled. The primary objective of this clinical study is to monitor complications related to the NEMOST growth domino during a 5-year postoperative follow-up in patients treated for progressive scoliosis in children.

The secondary objective of this clinical study is to monitor the performance of the NEMOST growth domino during a 5-year postoperative follow-up in patients treated for progressive scoliosis in children.

The study will include 140 patients.

The group in the trial

  • NEMOST V2Treatment being tested

    Treatment: NEMOST V2 growing domino

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Post-market Clinical Follow-up Study of NEMOST V2 Growing Domino
Criteria questions
Built from NCT07403084, who can take part
Record updated
11 February 2026